---
category: news
title: "BioXcel Therapeutics Announces $260 Million Strategic Financing with Oaktree and Qatar Investment Authority"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI) (the “Company” or “BioXcel Therapeutics”), a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,"
publishedDateTime: 2022-04-19T11:13:00Z
originalUrl: "https://www.tmcnet.com/usubmit/2022/04/19/9584691.htm"
webUrl: "https://www.tmcnet.com/usubmit/2022/04/19/9584691.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "BioXcel Therapeutics Announces Formation of OnkosXcel Therapeutics to Develop Medicines Focused in Oncology"
    excerpt: "OnkosXcel, a Company subsidiary, to utilize proprietary AI-powered platform to progress therapies to address difficult-to-treat cancers with high unmet need New structure to unlock growth opportunities and maximize value of neuroscience and immuno-oncology franchises Lead pipeline asset,"
    publishedDateTime: 2022-04-19T11:07:00Z
    webUrl: "https://apnews.com/press-release/globe-newswire/technology-health-business-prostate-cancer-294d1a6f52446dd5a66692042cb834e3"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 0

secured: "0q1+Y8iE8UQ/9lLazHBROhthJx9c+KSS+SUyQbfAGR6vuaZt0WSydqD9BSISzmGaZ5KI/KJ0PdZKx4aUVnEX5B6vQbjPsvnqQujrc1Izq+G2tjqvHfK0nZRiXryQw4+FuV2fkYAm8lwhOH77/W6r3ho9TDW3FunWNHlZD7g4sNX51h+MPRoAY1k+aXItgyAyoa0kxg4BSVXlp6nzQW3c+6HC9NWSffnmD0sfODUXImQiyZOx3cbIZePPSLfpGqKBgMEVnXdl7mNmJmUGzwO2KR+FP+9Qp57RlhS/PmpeVwIkdrAjtymDwUGlUUXe+fsktlEAkzM9DNVWDaurt/5cxqqdl7npf7DVKTSTMow01Xc=;bw9ktoVsq4utkUAOYnZqUQ=="
---

